. home.aspx



Drug prices come under fire as US pharma lobby nears spending records

April 23, 2019 / europeanpharmaceuticalreview

More ambitious changes may be needed to lower pharmaceutical prices as the Trump administration proposes new rules and approves a slew of new generic drugs. Large drug makers and the pharmaceutical industry’s primary trade group neared previous spending records on lobbying in the first three months of 2019 as President Donald Trump and US Congress increase pressure to reduce the cost of medicine.